# Silodosin

## Urief F.C. 8mg

| TAH Drug Code      | [OURI8](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OURI8)                                                                                                                                                                                                                                                                   |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of signs and symptoms of benign prostatic hyperplasia (BPH).                                                                                                                                                                                                                                                                   |
| Dosing             | 4 mg BID， after breakfast and evening meal. Or 8mg QD after meal.                                                                                                                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | 1. Patients with a known history of hypersensitivity to any component of this product. 2. Patients with severe renal impairment (CCr <30 mL/min). 3. Patients with severe hepatic impairment (Child-Pugh score ?10). 4. Concomitant use with strong CYP3A4 inhibitors (e.g.， ketoconazole， clarithromycin， itraconazole， ritonavir). |
| Adverse Effects    | Drowsiness， postural hypotension， syncope， asthenia， depression， headache， dry mouth， GI disturbances， edema， blurred vision， rhinitis， erectile disorders， tachycardia， palpitation， hypersensitivity reactions; flushes; chest pain; dizziness; lack of energy.                                                          |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/silodosin-drug-information)                                                                                                                                                                                                                                                                 |

